160 related articles for article (PubMed ID: 20464150)
1. [Adverse reactions in Chagas disease patients treated with benznidazole, in the State of Ceará].
de Pontes VM; Souza Júnior AS; Cruz FM; Coelho HL; Dias AT; Coêlho IC; Oliveira Mde F
Rev Soc Bras Med Trop; 2010; 43(2):182-7. PubMed ID: 20464150
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the toxicity of two treatment schemes with benznidazole for chronic Chagas disease: a prospective cohort study in two Spanish referral centres.
Crespillo-Andújar C; López-Vélez R; Trigo E; Norman F; Díaz-Menéndez M; Monge-Maillo B; Arsuaga M; Pérez-Molina JA
Clin Microbiol Infect; 2020 Mar; 26(3):384.e1-384.e4. PubMed ID: 31740423
[TBL] [Abstract][Full Text] [Related]
3. Nifurtimox therapy for Chagas disease does not cause hypersensitivity reactions in patients with such previous adverse reactions during benznidazole treatment.
Pérez-Molina JA; Sojo-Dorado J; Norman F; Monge-Maillo B; Díaz-Menéndez M; Albajar-Viñas P; López-Vélez R
Acta Trop; 2013 Aug; 127(2):101-4. PubMed ID: 23583863
[TBL] [Abstract][Full Text] [Related]
4. Seronegative conversion after incomplete benznidazole treatment in chronic Chagas disease.
Alvarez MG; Vigliano C; Lococo B; Petti M; Bertocchi G; Viotti R
Trans R Soc Trop Med Hyg; 2012 Oct; 106(10):636-8. PubMed ID: 22898619
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of cytokine profile and HLA association in benznidazole related cutaneous reactions in patients with Chagas disease.
Salvador F; Sánchez-Montalvá A; Martínez-Gallo M; Sala-Cunill A; Viñas L; García-Prat M; Aparicio G; Sao Avilés A; Artaza MÁ; Ferrer B; Molina I
Clin Infect Dis; 2015 Dec; 61(11):1688-94. PubMed ID: 26265500
[TBL] [Abstract][Full Text] [Related]
6. Technological innovation strategies for the specific treatment of Chagas disease based on Benznidazole.
Ferraz LRM; Alves AÉG; Nascimento DDSDS; Amariz IAE; Ferreira AS; Costa SPM; Rolim LA; Lima ÁAN; Rolim Neto PJ
Acta Trop; 2018 Sep; 185():127-132. PubMed ID: 29452113
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of posaconazole and benznidazole for chronic Chagas' disease.
Molina I; Gómez i Prat J; Salvador F; Treviño B; Sulleiro E; Serre N; Pou D; Roure S; Cabezos J; Valerio L; Blanco-Grau A; Sánchez-Montalvá A; Vidal X; Pahissa A
N Engl J Med; 2014 May; 370(20):1899-908. PubMed ID: 24827034
[TBL] [Abstract][Full Text] [Related]
8. What to expect and when: benznidazole toxicity in chronic Chagas' disease treatment.
Aldasoro E; Posada E; Requena-Méndez A; Calvo-Cano A; Serret N; Casellas A; Sanz S; Soy D; Pinazo MJ; Gascon J
J Antimicrob Chemother; 2018 Apr; 73(4):1060-1067. PubMed ID: 29351667
[TBL] [Abstract][Full Text] [Related]
9. Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial.
Torrico F; Gascon J; Ortiz L; Alonso-Vega C; Pinazo MJ; Schijman A; Almeida IC; Alves F; Strub-Wourgaft N; Ribeiro I;
Lancet Infect Dis; 2018 Apr; 18(4):419-430. PubMed ID: 29352704
[TBL] [Abstract][Full Text] [Related]
10. Adverse events after the use of benznidazole in infants and children with Chagas disease.
Altcheh J; Moscatelli G; Moroni S; Garcia-Bournissen F; Freilij H
Pediatrics; 2011 Jan; 127(1):e212-8. PubMed ID: 21173000
[TBL] [Abstract][Full Text] [Related]
11. Does Progressive Introduction of Benznidazole Reduce the Chance of Adverse Events in the Treatment of Chagas Disease?
Losada Galván I; Madrid Pascual O; Herrero-Martínez JM; Pérez-Ayala A; Lizasoain Hernández M
Am J Trop Med Hyg; 2019 Jun; 100(6):1477-1481. PubMed ID: 30938285
[TBL] [Abstract][Full Text] [Related]
12. Arthritis and benznidazole: more closely related than we thought.
Aldasoro E; Pinazo MJ; Oliveira I; Munoz J; Posada E; Requena-Méndez A; Serret N; Gascon J
Antimicrob Agents Chemother; 2015 Jan; 59(1):727-9. PubMed ID: 25385100
[TBL] [Abstract][Full Text] [Related]
13. Characterization of adverse reactions to benznidazole in patients with Chagas disease in the Federal District, Brazil.
Gontijo MKCL; Arruda HMBDS; Noronha EF; Toledo MI
Rev Soc Bras Med Trop; 2020; 53():e20190150. PubMed ID: 31994658
[TBL] [Abstract][Full Text] [Related]
14. Side effects of benznidazole treatment in a cohort of patients with Chagas disease in non-endemic country.
Carrilero B; Murcia L; Martínez-Lage L; Segovia M
Rev Esp Quimioter; 2011 Sep; 24(3):123-6. PubMed ID: 21947093
[TBL] [Abstract][Full Text] [Related]
15. Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities.
Viotti R; Vigliano C; Lococo B; Alvarez MG; Petti M; Bertocchi G; Armenti A
Expert Rev Anti Infect Ther; 2009 Mar; 7(2):157-63. PubMed ID: 19254164
[TBL] [Abstract][Full Text] [Related]
16. Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Médecins Sans Frontières.
Yun O; Lima MA; Ellman T; Chambi W; Castillo S; Flevaud L; Roddy P; Parreño F; Albajar Viñas P; Palma PP
PLoS Negl Trop Dis; 2009 Jul; 3(7):e488. PubMed ID: 19582142
[TBL] [Abstract][Full Text] [Related]
17. Benznidazole-related adverse drug reactions and their relationship to serum drug concentrations in patients with chronic chagas disease.
Pinazo MJ; Guerrero L; Posada E; Rodríguez E; Soy D; Gascon J
Antimicrob Agents Chemother; 2013 Jan; 57(1):390-5. PubMed ID: 23114763
[TBL] [Abstract][Full Text] [Related]
18. High frequency of adverse reactions and discontinuation with benznidazole treatment for chronic Chagas disease in Milan, Italy.
Antinori S; Grande R; Bianco R; Traversi L; Cogliati C; Torzillo D; Repetto E; Corbellino M; Milazzo L; Galli M; Galimberti L
Clin Infect Dis; 2015 Jun; 60(12):1873-5. PubMed ID: 25805302
[No Abstract] [Full Text] [Related]
19. New Scheme of Intermittent Benznidazole Administration in Patients Chronically Infected with Trypanosoma cruzi: a Pilot Short-Term Follow-Up Study with Adult Patients.
Álvarez MG; Hernández Y; Bertocchi G; Fernández M; Lococo B; Ramírez JC; Cura C; Albizu CL; Schijman A; Abril M; Sosa-Estani S; Viotti R
Antimicrob Agents Chemother; 2016 Feb; 60(2):833-7. PubMed ID: 26596935
[TBL] [Abstract][Full Text] [Related]
20. Adverse systemic reaction to benznidazole.
Coronel MV; Frutos LO; Muñoz EC; Valle DK; Rojas DH
Rev Soc Bras Med Trop; 2017; 50(1):145-147. PubMed ID: 28327820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
